Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis

NCT05079854 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.

NCT NCT05079854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05079854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use Of Intracameral Moxifloxacin For Prophylaxis Of Open Globe Endophthalmitis
Lead sponsor
Federal University of São Paulo
Phase
Phase 4
Overall status
Unknown status
Start date
October 1, 2021
Completion date
November 1, 2023
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endophthalmitis, trauma, corneal